EGFR mutation detection by microfluidic technology: a validation study.

Abstract

Advanced non-small cell lung cancer samples are tested for epidermal growth factor receptor (EGFR) gene mutations. Their detection by direct sequencing is time-consuming. Conversely, the length analysis of fluorescently labelled PCR products is easier. To avoid labelled primers and the automated capillary electrophoresis apparatus, we validated a fast and… (More)
DOI: 10.1136/jclinpath-2013-201730

Topics

Cite this paper

@article{Malapelle2013EGFRMD, title={EGFR mutation detection by microfluidic technology: a validation study.}, author={Umberto Malapelle and Stefania Russo and Francesco Pepe and Roberta Sgariglia and Caterina de Luca and Claudio Bellevicine and Pierlorenzo Pallante and Giancarlo Troncone}, journal={Journal of clinical pathology}, year={2013}, volume={66 11}, pages={982-4} }